Biotechnology Value Fund, L.P. Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotechnology Value Fund, L.P.

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: scaram(o)uche who started this subject	11/10/2000 10:48:11 AM
From: nigel bates	Read Replies (1) of 4974

10 /PRNewswire/ -- Immunex Corporation (Nasdaq: IMNX - news) announced today the pricing of its public offering of 70 million shares of common stock at $39.75 per share. Of the 70 million shares offered, 20 million shares are newly issued shares of common stock being offered by Immunex, and 50 million shares are being offered by American Home Products Corporation (NYSE: AHP - news) from its existing holdings of Immunex common stock. In addition, AHP has granted the underwriters an option to purchase up to 10.5 million additional shares to cover over-allotments, if any.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next